# GSI Technology Inc: overview

GSIT · Nasdaq · CIK 1126741 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/gsit.md) · [Financials](/companies/gsit/financials.md) · [Filings](/companies/gsit/filings.md) · [Insiders](/companies/gsit/insiders.md)

Latest reported revenue: [$6.3m](/filings/0001104659-26-094044.md) for Q1 FY2027, three months to 2026-06-30, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001104659-26-094044).

## Last eight quarters

| Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [4,550](/filings/0001104659-25-108467.md) | [5,414](/filings/0001104659-26-011501.md) | [5,883 d](/filings/0001104659-26-070962.md) | [6,283](/filings/0001104659-26-094044.md) | [6,444](/filings/0001104659-25-108467.md) | [6,076](/filings/0001104659-26-011501.md) | [6,319 d](/filings/0001104659-26-070962.md) | [6,312](/filings/0001104659-26-094044.md) |
| Gross margin | % | [38.6%](/filings/0001104659-25-108467.md) | [54.0%](/filings/0001104659-26-011501.md) | [56.1% d](/filings/0001104659-26-070962.md) | [58.1%](/filings/0001104659-26-094044.md) | [54.8%](/filings/0001104659-25-108467.md) | [52.7%](/filings/0001104659-26-011501.md) | [52.4% d](/filings/0001104659-26-070962.md) | [53.4%](/filings/0001104659-26-094044.md) |
| Operating margin | % | [(122.7%)](/filings/0001104659-25-108467.md) | [(74.9%)](/filings/0001104659-26-011501.md) | [(38.7%) d](/filings/0001104659-26-070962.md) | [(34.6%)](/filings/0001104659-26-094044.md) | [(49.5%)](/filings/0001104659-25-108467.md) | [(113.7%)](/filings/0001104659-26-011501.md) | [(82.4%) d](/filings/0001104659-26-070962.md) | [(85.3%)](/filings/0001104659-26-094044.md) |
| Net margin | % | [(120.0%)](/filings/0001104659-25-108467.md) | [(74.4%)](/filings/0001104659-26-011501.md) | [(37.9%) d](/filings/0001104659-26-070962.md) | [(35.3%)](/filings/0001104659-26-094044.md) | [(49.4%)](/filings/0001104659-25-108467.md) | [(49.7%)](/filings/0001104659-26-011501.md) | [(76.3%) d](/filings/0001104659-26-070962.md) | [(75.9%)](/filings/0001104659-26-094044.md) |
| Diluted EPS | $ per share | [(0.21)](/filings/0001104659-25-108467.md) | [(0.16)](/filings/0001104659-26-011501.md) | not reported | [(0.08)](/filings/0001104659-26-094044.md) | [(0.11)](/filings/0001104659-25-108467.md) | [(0.09)](/filings/0001104659-26-011501.md) | not reported | [(0.13)](/filings/0001104659-26-094044.md) |
| Free cash flow | $k | [(3,486) d](/filings/0001104659-25-108467.md) | [(3,576) d](/filings/0001104659-26-011501.md) | [(1,662) d](/filings/0001104659-26-070962.md) | [(1,733)](/filings/0001104659-26-094044.md) | [(906) d](/filings/0001104659-25-108467.md) | [(8,168) d](/filings/0001104659-26-011501.md) | [(5,602) d](/filings/0001104659-26-070962.md) | [(4,216)](/filings/0001104659-26-094044.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [33.4](/filings/0001558370-24-009139.md) | [29.7](/filings/0001558370-25-008723.md) | [21.8](/filings/0001104659-26-070962.md) | [20.5](/filings/0001104659-26-070962.md) | [25.1](/filings/0001104659-26-070962.md) |
| Gross margin | % | [55.5%](/filings/0001558370-24-009139.md) | [59.6%](/filings/0001558370-25-008723.md) | [54.3%](/filings/0001104659-26-070962.md) | [49.4%](/filings/0001104659-26-070962.md) | [54.5%](/filings/0001104659-26-070962.md) |
| Operating margin | % | [(49.0%)](/filings/0001558370-24-009139.md) | [(53.2%)](/filings/0001558370-25-008723.md) | [(93.9%)](/filings/0001104659-26-070962.md) | [(52.8%)](/filings/0001104659-26-070962.md) | [(69.6%)](/filings/0001104659-26-070962.md) |
| Net margin | % | [(49.0%)](/filings/0001558370-24-009139.md) | [(53.8%)](/filings/0001558370-25-008723.md) | [(92.3%)](/filings/0001104659-26-070962.md) | [(51.9%)](/filings/0001104659-26-070962.md) | [(52.7%)](/filings/0001104659-26-070962.md) |
| Diluted EPS | $ per share | [(0.67)](/filings/0001558370-24-009139.md) | [(0.65)](/filings/0001558370-25-008723.md) | [(0.80)](/filings/0001104659-26-070962.md) | [(0.42)](/filings/0001104659-26-070962.md) | [(0.42)](/filings/0001104659-26-070962.md) |
| Free cash flow | $m | [(14.6)](/filings/0001558370-24-009139.md) | [(17.2)](/filings/0001558370-25-008723.md) | [(18.0)](/filings/0001104659-26-070962.md) | [(13.0)](/filings/0001104659-26-070962.md) | [(16.4)](/filings/0001104659-26-070962.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gsit/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $18.6m | 2,399,846 |  | Added +1,855,848 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $10.4m | 1,350,367 |  | Added +71,935 |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $8.7m | 1,122,703 |  | Added +483,676 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $6.8m | 875,894 |  | Added +345,690 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $6.2m | 801,890 |  | Added +451,196 |
| [Silverberg Bernstein Capital Management LLC](/funds/2007880.md) | 2026-06-30 | $6.1m | 783,306 |  | Reduced −2,400 |
| [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $3.6m | 469,032 |  | Added +29,032 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $3.1m | 406,972 |  | Added +268,130 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $3.1m | 402,700 | Call | Added +285,800 |
| [Qube Research & Technologies Ltd](/funds/1729829.md) | 2026-06-30 | $2.7m | 351,384 |  | Added +333,975 |

## Recent filings

[All 812 filings](/companies/gsit/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-21 | 16:05 ET | [8-K](/filings/0001104659-26-099675.md) | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-099675 |
| 2026-08-11 | 16:06 ET | [10-Q](/filings/0001104659-26-094044.md) | Quarterly report, period 2026-06-30 | 0001104659-26-094044 |
| 2026-07-30 | 16:05 ET | [8-K](/filings/0001171843-26-005079.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005079 |
| 2026-07-16 | 16:05 ET | [DEF 14A](/filings/0001104659-26-084241.md) | Proxy statement, period 2026-08-20 | 0001104659-26-084241 |
| 2026-06-05 | 16:05 ET | [10-K](/filings/0001104659-26-070962.md) | Annual report, period 2026-03-31 | 0001104659-26-070962 |
| 2026-05-28 | 16:05 ET | [8-K](/filings/0001104659-26-067475.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-067475 |
| 2026-05-22 | 06:03 ET | [8-K](/filings/0001104659-26-065370.md) | 2.02 Results of operations; 8.01 Other events | 0001104659-26-065370 |
| 2026-05-07 | 16:07 ET | [8-K](/filings/0001171843-26-003155.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003155 |
| 2026-03-18 | 08:30 ET | [8-K](/filings/0001171843-26-001697.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-001697 |
| 2026-02-18 | 07:51 ET | [SCHEDULE 13D](/filings/0001731122-26-000264.md) | Ownership report, active investor | 0001731122-26-000264 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001104659-26-070962.md), filed Jun 5, 2026.

## Forecast league

Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/10f63eb1-9274-4758-b78f-16f7c38bb1fa)

## About the filer

- CIK: 1126741
- Tickers: GSIT
- Exchange: Nasdaq
- SIC code: 3674 Semiconductors & Related Devices
- State of incorporation: DE
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.
